MB

Michael Baker

Percheron Therapeutics Limited | Chief Executive Officer, Managing Director
Dr Baker is a biotech executive and public company CEO. His most recent role was as Chief Executive Officer and Managing Director of Arovella Therapeutics (ASX: ALA). Prior to joining Arovella, he served as a senior executive at a Australian biotechnology-focused venture capital fund..

Company and Roles

Company
Title
Tenure
Since
PER
PER
Percheron Therapeutics Limited
  • Chief Executive Officer
  • Managing Director
Just startedOct 2026

Holdings

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
PER
PER
Percheron Therapeutics Limited
05/10/260N/AN/AN/A
ALA
ALA
04/05/2608,184,4935,668,280N/A
RAD
RAD
08/12/23N/A117,4111,906,262N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
PER
PER
Percheron Therapeutics Limited
08/10/26
Issued
75,000,000$0.004$300,000Issue of securities
ALA
ALA
10/11/25
Issued
1,831,266$0.089$162,982Issue of options
ALA
ALA
13/10/25
Expiry
6,382,979$0.094$600,000Options expired
ALA
ALA
13/10/25
Issued
1,617,021$0.075$121,276Exercise of options
ALA
ALA
13/10/25
Exercise
1,617,021$0.075$121,276Exercise of options